Avalo Therapeutics Inc

NASDAQ:AVTX   3:59:54 PM EDT
2.03
-0.06 (-2.87%)
Earnings Announcements

Avalo Posts Quarterly Loss Per Share Of $0.17

Published: 11/09/2021 21:57 GMT
Avalo Therapeutics Inc (AVTX) - Avalo Reports Third Quarter 2021 Financial Results and Provides Business Updates.
Qtrly Loss per Share $0.17.
Q3 Earnings per Share View $-0.18 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.9 Million
Adjusted EPS is expected to be -$0.16

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.16

More details on our Analysts Page.